[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

Evelyn E. C. de Jong; Wouter van Elmpt; Ralph T. H. Leijenaar; Otto S. Hoekstra; Harry J. M. Groen; Egbert F. Smit; Ronald Boellaard; Vincent van der Noort; Esther G. C. Troost; Philippe Lambin; Anne-Marie C. Dingemans

doi:https://doi.org/10.1007/s00259-016-3498-y

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

Evelyn E. C. de Jong, Wouter van Elmpt, Ralph T. H. Leijenaar, Otto S. Hoekstra, Harry J. M. Groen, Egbert F. Smit, Ronald Boellaard, Vincent van der Noort, Esther G. C. Troost, Philippe Lambin, Anne-Marie C. Dingemans

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	8-16
Journal	European journal of nuclear medicine and molecular imaging
Volume	44
Issue number	1
DOIs	https://doi.org/10.1007/s00259-016-3498-y
Publication status	Published - Jan 2017

Keywords

Bevacizumab
Nitroglycerin
Response assessment
Stage IV NSCLC
[18F]FDG PET/CT

Access to Document

https://doi.org/10.1007/s00259-016-3498-y

Cite this

de Jong, E. E. C., van Elmpt, W., Leijenaar, R. T. H., Hoekstra, O. S., Groen, H. J. M., Smit, E. F., Boellaard, R., van der Noort, V., Troost, E. G. C., Lambin, P., & Dingemans, A.-M. C. (2017). [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches. European journal of nuclear medicine and molecular imaging, 44(1), 8-16. https://doi.org/10.1007/s00259-016-3498-y

@article{fe9481c9cb4b4f08bd26f289151f3a3d,

title = "[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches",

keywords = "Bevacizumab, Nitroglycerin, Response assessment, Stage IV NSCLC, [18F]FDG PET/CT",

author = "{de Jong}, {Evelyn E. C.} and {van Elmpt}, Wouter and Leijenaar, {Ralph T. H.} and Hoekstra, {Otto S.} and Groen, {Harry J. M.} and Smit, {Egbert F.} and Ronald Boellaard and {van der Noort}, Vincent and Troost, {Esther G. C.} and Philippe Lambin and Dingemans, {Anne-Marie C.}",

year = "2017",

month = jan,

doi = "https://doi.org/10.1007/s00259-016-3498-y",

language = "English",

volume = "44",

pages = "8--16",

journal = "European journal of nuclear medicine and molecular imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "1",

}

de Jong, EEC, van Elmpt, W, Leijenaar, RTH, Hoekstra, OS, Groen, HJM, Smit, EF, Boellaard, R, van der Noort, V, Troost, EGC, Lambin, P & Dingemans, A-MC 2017, '[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches', European journal of nuclear medicine and molecular imaging, vol. 44, no. 1, pp. 8-16. https://doi.org/10.1007/s00259-016-3498-y

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches. / de Jong, Evelyn E. C.; van Elmpt, Wouter; Leijenaar, Ralph T. H. et al.
In: European journal of nuclear medicine and molecular imaging, Vol. 44, No. 1, 01.2017, p. 8-16.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

AU - de Jong, Evelyn E. C.

AU - van Elmpt, Wouter

AU - Leijenaar, Ralph T. H.

AU - Hoekstra, Otto S.

AU - Groen, Harry J. M.

AU - Smit, Egbert F.

AU - Boellaard, Ronald

AU - van der Noort, Vincent

AU - Troost, Esther G. C.

AU - Lambin, Philippe

AU - Dingemans, Anne-Marie C.

PY - 2017/1

Y1 - 2017/1

KW - Bevacizumab

KW - Nitroglycerin

KW - Response assessment

KW - Stage IV NSCLC

KW - [18F]FDG PET/CT

U2 - https://doi.org/10.1007/s00259-016-3498-y

DO - https://doi.org/10.1007/s00259-016-3498-y

M3 - Article

C2 - 27600280

SN - 1619-7070

VL - 44

SP - 8

EP - 16

JO - European journal of nuclear medicine and molecular imaging

JF - European journal of nuclear medicine and molecular imaging

IS - 1

ER -

de Jong EEC, van Elmpt W, Leijenaar RTH, Hoekstra OS, Groen HJM, Smit EF et al. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches. European journal of nuclear medicine and molecular imaging. 2017 Jan;44(1):8-16. doi: https://doi.org/10.1007/s00259-016-3498-y